Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
BDNF as a promising therapeutic agent in Parkinson's disease
E Palasz, A Wysocka, A Gasiorowska… - International journal of …, 2020 - mdpi.com
Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration.
In animal models of Parkinson's disease (PD), BDNF enhances the survival of dopaminergic …
In animal models of Parkinson's disease (PD), BDNF enhances the survival of dopaminergic …
Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases
T Numakawa, H Odaka, N Adachi - International journal of molecular …, 2018 - mdpi.com
It is well known that brain-derived neurotrophic factor, BDNF, has an important role in a
variety of neuronal aspects, such as differentiation, maturation, and synaptic function in the …
variety of neuronal aspects, such as differentiation, maturation, and synaptic function in the …
Mechanisms of α-synuclein induced synaptopathy in Parkinson's disease
JC Bridi, F Hirth - Frontiers in neuroscience, 2018 - frontiersin.org
Parkinson's disease (PD) is characterized by intracellular inclusions of aggregated and
misfolded α-Synuclein (α-Syn), and the loss of dopaminergic (DA) neurons in the brain. The …
misfolded α-Synuclein (α-Syn), and the loss of dopaminergic (DA) neurons in the brain. The …
Cellular and molecular basis of neurodegeneration in Parkinson disease
XS Zeng, WS Geng, JJ Jia, L Chen… - Frontiers in aging …, 2018 - frontiersin.org
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in
1817. The disease is the second most common neurodegenerative disease characterized …
1817. The disease is the second most common neurodegenerative disease characterized …
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
Abstract The endosome-associated GTPase Rab5 is a central player in the molecular
mechanisms leading to degeneration of basal forebrain cholinergic neurons (BFCN), a long …
mechanisms leading to degeneration of basal forebrain cholinergic neurons (BFCN), a long …
The possible role of brain-derived neurotrophic factor in epilepsy
Epilepsy is a neurological disease characterized by repeated seizures. Despite of that the
brain-derived neurotrophic factor (BDNF) is implicated in the pathogenesis of …
brain-derived neurotrophic factor (BDNF) is implicated in the pathogenesis of …
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Parkinson's disease (PD) is a neurodegenerative disorder of the brain and is manifested by
motor and non‐motor symptoms because of degenerative changes in dopaminergic …
motor and non‐motor symptoms because of degenerative changes in dopaminergic …
[HTML][HTML] Endosomal dysfunction induced by directly overactivating Rab5 recapitulates prodromal and neurodegenerative features of Alzheimer's disease
Neuronal endosomal dysfunction, the earliest known pathobiology specific to Alzheimer's
disease (AD), is mediated by the aberrant activation of Rab5 triggered by APP-β secretase …
disease (AD), is mediated by the aberrant activation of Rab5 triggered by APP-β secretase …
CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons
Huntington's disease (HD) is caused by an expanded CAG repeat in the huntingtin gene,
yielding a Huntingtin protein with an expanded polyglutamine tract. While experiments with …
yielding a Huntingtin protein with an expanded polyglutamine tract. While experiments with …
[HTML][HTML] LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease
LRRK2 has been implicated in endolysosomal function and likely plays a central role in
idiopathic Parkinson's disease (iPD). In iPD, dopaminergic neurons within the substantia …
idiopathic Parkinson's disease (iPD). In iPD, dopaminergic neurons within the substantia …